SCHEMBL14926294

SCHEMBL14926294

Brc1ccc(N(c2ccccc2)c2cccc(-c3cccnc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.51
CYP11B2 P19099 2/20 0.51
MEN1 O00255 1/20 0.45
PSIP1 O75475 1/20 0.45
AXL P30530 1/20 0.45
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
USP8 P40818 1/20 0.45
KMO O15229 1/20 0.44
CYP2A6 P11509 3/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP19A1 P11511 3/20 0.44
CYP17A1 P05093 1/20 0.44
FYN P06241 1/20 0.41
MAPT P10636 2/20 0.40
FGFR1 P11362 1/20 0.39
EPHX2 P34913 1/20 0.39
PRMT6 Q96LA8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16484501 0.91 CYP2A6 (0.54) CYP11B1CYP11B2MEN1PSIP1AXL
SCHEMBL18090365 0.89 CYP11B1 (0.47) CYP11B1CYP11B2MEN1PSIP1AXL
SCHEMBL12130070 0.86 MKNK1 (0.49) CYP11B1CYP11B2MEN1PSIP1AXL
SCHEMBL20664609 0.84 CYP11B2 (0.56) CYP11B1CYP11B2MKNK1MKNK2CYP2A6
SCHEMBL10040769 0.84 CYP2A6 (0.58) CYP11B1CYP11B2MEN1PSIP1AXL
SCHEMBL17402575 0.84 ALDH1A1 (0.52) MEN1MKNK2ALDH1A1CYP1A2CYP3A4
SCHEMBL16601114 0.82 ALDH1A1 (0.56) MEN1ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL17402610 0.82 ALDH1A1 (0.56) MEN1ALDH1A1CYP1A2CYP3A4CYP19A1
SCHEMBL15237258 0.82 HDAC6 (0.45) CYP11B1CYP11B2USP8ALDH1A1CYP1A2
SCHEMBL19429292 0.82 ALDH1A1 (0.50) MEN1MKNK2KMOALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130112948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-05-09 US disclosed
US-20130112948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130112948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME CYP1B1, CYP1A1, CRY1 CYP11B1 113/4885CYP11B2 128/4885MEN1 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.